Govt issues guidelines on GLP-1 Drugs' use, risks, and regualtions

Apr 01, 2026

The Government of India on Thursday released details on the GLP -1 Drugs' use, risks, and regulation, according to an official press release.

COVID-19: Expert committee recommends restricted emergency use of SII, Bharat Biotech's vaccines

Jan 02, 2021

New Delhi [India], January 2 : The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs...

COVID-19: Indiscriminate use of Remdesivir and Tocilizumab can cause more harm than good, says Health Ministry

Jul 11, 2020

New Delhi [India], July 11 : While the Central government has indicated drugs like Remdesivir and Tocilizumab as an "investigational therapies" for the treatment...

DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-19 infection

Apr 23, 2021

New Delhi [India], April 23 : Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the...

DCGI gives emergency use authorisation to Covaxin for 6-12 age group

Apr 26, 2022

New Delhi [India], April 26 : The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age...

DCGI approves '5-arms intranasal hetrologous booster dose' for restricted use

Nov 25, 2022

The Drugs Controller General of India (DCGI) has given approval to intranasal "Five Arms" booster dose for restricted use for COVID-19 patients, it is...